CBD Life Sciences Inc. (CBDL) Announces a Product that may Assist Autism, Depression, & PTSD
Back to Newsroom
Mentioned in this Article

CBD Life Sciences Inc. (CBDL) Announces a Product that may Assist Autism, Depression, & PTSD

Thursday, January 7, 2021 7:00 AM
Share this article now
Topic:
Company Update

SCOTTSDALE, AZ / ACCESSWIRE / January 7, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces a product that may assist Autism, Depression, & PTSD.

CBD Life Sciences has liters upon liters of Full Spectrum Oil at its Greenhouse Facility & this is wonderful news to hear as the New Year kicks off! This also expands opportunity for the companies upcoming future products as well. President & CEO, Lisa Nelson states "This Oil may help with these disorders and we are in the works of talking to Healthcare Organizations, Non-Profit Organizations, & Rehabilitation Centers regarding our product line". "Working with big amounts of Full Spectrum also opens up many doors for our company and this is going to be a great year"!

CBD can help in numerous ways to alleviate disorders often associated with autism such as epilepsy, anxiety, sleeplessness, and stress. For example, it may cause better sleep and lower anxiety (which can reduce aggressive behaviors), fewer seizures (which can lessen stress and make it easier to interact socially), and lower anxiety to make it easier to learn and use social communication skills. It's also important to note that sleeplessness and aggression are particularly difficult symptoms for parents, who can quickly find themselves exhausted and overwhelmed. Aggression is one of the most challenging behaviors common to Autism.

As far as the Healthcare Industry goes, those who are addicted to drugs have a compulsive need to use and are not able to control the amount they're using. Multiple studies have suggested that CBD could contain therapeutic properties to help treat psychostimulant addition, as well as opioid and cocaine addiction. The road to treatment with CBD is exciting and full of possibilities. Additional research and studies are needed to keep the ball rolling on this being a potential treatment for a variety of ailments and illnesses.

Link to Facility Video: https://streamable.com/fxrext

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100mg CBD Bath Bombs, CBD Flower, CBD Hemp Smokes, 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Why Shop LBC Bioscience?

  • Large Selection of Products (over 50 items and growing)
  • 100% USA Made Products "organic & kosher"
  • 40% off on all products using code "LBC40"

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:

LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.

Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: [email protected]
Website: www.tenassociatesllc.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking

SOURCE: CBD Life Sciences Inc.

CBD Life Sciences Inc.
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: